NCT00138970View on ClinicalTrials.gov

Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

February 28, 2005

Conditions
Renal Transplant Recipients
Interventions
DRUG

Zenapax®, CellCept® and prednisolone

DRUG

Sandimmun Neoral®, CellCept® and prednisolone

All Listed Sponsors
lead

University of Oslo School of Pharmacy

OTHER

NCT00138970 - Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk | Biotech Hunter | Biotech Hunter